Company registration number 13964280 (England and Wales)
Camden Place Dental Implant Centre Limited
Unaudited financial statements
For the year ended 31 March 2025
CAMDEN PLACE DENTAL IMPLANT CENTRE LIMITED
Camden Place Dental Implant Centre Limited
Company information
Director
Dr Hamza Sheikh
Company number
13964280
Registered office
6 Camden Place
PRESTON
PR1 3JL
Accountants
DJH Chester Limited
Chester House
Lloyd Drive
Cheshire Oaks Business Park
Ellesmere Port
England
CH65 9HQ
CAMDEN PLACE DENTAL IMPLANT CENTRE LIMITED
Camden Place Dental Implant Centre Limited
Contents
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 9
Camden Place Dental Implant Centre Limited
Statement of financial position
As at 31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
4
1,297,200
1,324,800
Tangible assets
5
89,074
57,386
1,386,274
1,382,186
Current assets
Stocks
4,500
4,500
Debtors
6
435,938
454,108
Cash at bank and in hand
425,280
102,337
865,718
560,945
Creditors: amounts falling due within one year
7
(442,932)
(525,784)
Net current assets
422,786
35,161
Total assets less current liabilities
1,809,060
1,417,347
Creditors: amounts falling due after more than one year
8
(17,403)
(7,854)
Net assets
1,791,657
1,409,493
Capital and reserves
Called up share capital
1,382,025
1,382,025
Profit and loss reserves
409,632
27,468
Total equity
1,791,657
1,409,493
Camden Place Dental Implant Centre Limited
Statement of financial position (continued)
As at 31 March 2025
- 2 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 21 June 2025
Dr Hamza Sheikh
Director
Company registration number 13964280 (England and Wales)
CAMDEN PLACE DENTAL IMPLANT CENTRE LIMITED
Camden Place Dental Implant Centre Limited
Notes to the financial statements
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

Camden Place Dental Implant Centre Limited is a private company limited by shares incorporated in England and Wales. The registered office is 6 Camden Place, PRESTON, PR1 3JL.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on despatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

CAMDEN PLACE DENTAL IMPLANT CENTRE LIMITED
Camden Place Dental Implant Centre Limited
Notes to the financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
20% Reducing balance method
Fixtures and fittings
25% Reducing balance method
Computers
33.33% Straight line method

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

CAMDEN PLACE DENTAL IMPLANT CENTRE LIMITED
Camden Place Dental Implant Centre Limited
Notes to the financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 5 -

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

CAMDEN PLACE DENTAL IMPLANT CENTRE LIMITED
Camden Place Dental Implant Centre Limited
Notes to the financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 6 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

CAMDEN PLACE DENTAL IMPLANT CENTRE LIMITED
Camden Place Dental Implant Centre Limited
Notes to the financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 7 -
1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases
As lessee

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the statement of financial position as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
9
7
CAMDEN PLACE DENTAL IMPLANT CENTRE LIMITED
Camden Place Dental Implant Centre Limited
Notes to the financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
4
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2024 and 31 March 2025
1,380,000
Amortisation and impairment
At 1 April 2024
55,200
Amortisation charged for the year
27,600
At 31 March 2025
82,800
Carrying amount
At 31 March 2025
1,297,200
At 31 March 2024
1,324,800
5
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Computers
Total
£
£
£
£
Cost
At 1 April 2024
70,870
9,072
1,822
81,764
Additions
48,175
-
0
2,150
50,325
At 31 March 2025
119,045
9,072
3,972
132,089
Depreciation and impairment
At 1 April 2024
19,802
3,969
607
24,378
Depreciation charged in the year
16,577
1,276
784
18,637
At 31 March 2025
36,379
5,245
1,391
43,015
Carrying amount
At 31 March 2025
82,666
3,827
2,581
89,074
At 31 March 2024
51,068
5,103
1,215
57,386
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
23,931
1,720
Other debtors
406,594
411,924
Prepayments and accrued income
5,413
40,464
435,938
454,108
CAMDEN PLACE DENTAL IMPLANT CENTRE LIMITED
Camden Place Dental Implant Centre Limited
Notes to the financial statements (continued)
FOR THE YEAR ENDED 31 MARCH 2025
- 9 -
7
Creditors: amounts falling due within one year
2025
2024
£
£
Obligations under finance leases
17,410
25,828
Trade creditors
6,237
41,232
Corporation tax
131,525
6,596
Other taxation and social security
7,445
4,175
Deferred income
127,798
234,230
Other creditors
133,136
201,459
Accruals and deferred income
19,381
12,264
442,932
525,784
8
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Obligations under finance leases
17,403
7,854
2025-03-31 2024-04-01 false false false 21 June 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Dr Hamza Sheikh 13964280 2024-04-01 2025-03-31 13964280 bus:Director1 2024-04-01 2025-03-31 13964280 bus:RegisteredOffice 2024-04-01 2025-03-31 13964280 2025-03-31 13964280 2024-03-31 13964280 core:NetGoodwill 2025-03-31 13964280 core:NetGoodwill 2024-03-31 13964280 core:PlantMachinery 2025-03-31 13964280 core:FurnitureFittings 2025-03-31 13964280 core:ComputerEquipment 2025-03-31 13964280 core:PlantMachinery 2024-03-31 13964280 core:FurnitureFittings 2024-03-31 13964280 core:ComputerEquipment 2024-03-31 13964280 core:WithinOneYear 2025-03-31 13964280 core:WithinOneYear 2024-03-31 13964280 core:AfterOneYear 2025-03-31 13964280 core:AfterOneYear 2024-03-31 13964280 core:CurrentFinancialInstruments 2025-03-31 13964280 core:CurrentFinancialInstruments 2024-03-31 13964280 core:ShareCapital 2025-03-31 13964280 core:ShareCapital 2024-03-31 13964280 core:RetainedEarningsAccumulatedLosses 2025-03-31 13964280 core:RetainedEarningsAccumulatedLosses 2024-03-31 13964280 core:Goodwill 2024-04-01 2025-03-31 13964280 core:PlantMachinery 2024-04-01 2025-03-31 13964280 core:FurnitureFittings 2024-04-01 2025-03-31 13964280 core:ComputerEquipment 2024-04-01 2025-03-31 13964280 2023-04-01 2024-03-31 13964280 core:NetGoodwill 2024-03-31 13964280 core:NetGoodwill 2024-04-01 2025-03-31 13964280 core:PlantMachinery 2024-03-31 13964280 core:FurnitureFittings 2024-03-31 13964280 core:ComputerEquipment 2024-03-31 13964280 2024-03-31 13964280 core:Non-currentFinancialInstruments 2025-03-31 13964280 core:Non-currentFinancialInstruments 2024-03-31 13964280 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13964280 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 13964280 bus:FRS102 2024-04-01 2025-03-31 13964280 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 13964280 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP